| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_628aeff036872039b7a36e80a984ed24 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16734
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-13034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-16034 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 |
| filingDate |
2018-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e34d10fede4a625ac77b240c5b9fb1e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2e0387c46f86009342f833c2a8de061 |
| publicationDate |
2019-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019068905-A2 |
| titleOfInvention |
FELINE VACCINES CONFERRING EARLY PROTECTION |
| abstract |
The present invention relates to the use of a vaccine composition comprising at least one feline calicivirus antigen and / or at least one feline leukemia virus antigen and / or at least one feline herpesvirus 1 antigen, for the suppression and / or treatment and / or prevention of a disease or disorder caused by feline calicivirus infection and / or feline leukemia virus and / or feline herpesvirus 1, respectively, in a feline, said vaccine composition being administered in a single administration to the feline. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114634564-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113308441-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114634564-B |
| priorityDate |
2017-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |